Chitogen
Chitogen Inc. is a medical device company dedicated to developing next-generation proprietary hemostatic products for controlling severe bleeding. Their products are designed for a wide range of applications including surgical, cardiovascular, dialysis, trauma, and military environments, focusing on non-absorbable topical solutions that promote rapid and safe hemostasis.
Industries
Nr. of Employees
small (1-50)
Chitogen
Products
Topical chitosan hemostatic pad for femoral access
Sterile topical hemostatic pad made from surface-treated chitosan fiber fleece intended to control bleeding at femoral vascular access sites and reduce compression time.
Topical chitosan hemostatic pad for radial access
Sterile chitosan-based hemostatic pad configured for radial access sites and intended for use with compression bands to reduce radial hold time and promote patent hemostasis.
Dialysis hemostatic pads (two pads per pouch)
Sterile pouches each containing two small topical chitosan hemostatic pads designed to reduce hold times and pressure on dialysis fistulae during post-dialysis hemostasis.
Duplex hemostatic dressing for trauma (developmental)
A dual-component hemostatic dressing combining surface-treated chitosan fiber with a hydrophilic polymer powder intended for severe/traumatic hemorrhage; currently undergoing field testing and preclinical evaluation.
Topical chitosan hemostatic pad for femoral access
Sterile topical hemostatic pad made from surface-treated chitosan fiber fleece intended to control bleeding at femoral vascular access sites and reduce compression time.
Topical chitosan hemostatic pad for radial access
Sterile chitosan-based hemostatic pad configured for radial access sites and intended for use with compression bands to reduce radial hold time and promote patent hemostasis.
Dialysis hemostatic pads (two pads per pouch)
Sterile pouches each containing two small topical chitosan hemostatic pads designed to reduce hold times and pressure on dialysis fistulae during post-dialysis hemostasis.
Duplex hemostatic dressing for trauma (developmental)
A dual-component hemostatic dressing combining surface-treated chitosan fiber with a hydrophilic polymer powder intended for severe/traumatic hemorrhage; currently undergoing field testing and preclinical evaluation.
Services
Online order intake and processing for sterile topical hemostatic pads and dialysis pouch products with billing and shipping address collection.
Provision of clinical application instructions, IFUs, white papers and trial data to support clinical adoption and user training.
Online order intake and processing for sterile topical hemostatic pads and dialysis pouch products with billing and shipping address collection.
Provision of clinical application instructions, IFUs, white papers and trial data to support clinical adoption and user training.
Expertise Areas
- Topical hemostatic device development
- Chitosan biomaterials and surface chemistry
- Interventional cardiology and vascular access hemostasis
- Dialysis vascular access hemostasis
Key Technologies
- Chitosan-based hemostatic fibers
- Surface treatment to modify ionic charge/pH
- Nonwoven fiber fleece fabrication
- Duplex hemostatic dressing (fiber + hydrophilic polymer powder)
News & Updates
Comparison of Two Methods for Transradial Hemostasis After Cardiac Catheterization and Impact on Post-Procedure Efficiency, January 2024.
A novel method using manual pressure on a hemostatic pad and ulnar compression as an alternative for radial sheath removal, published in March 2018.
A presentation on the clinical efficacy of SoftSeal-STF Hemostatic Pad at the American College of Cardiology's 66th Annual Scientific Session in 2017.
Chitogen's U.S. contract manufacturer is ISO 13485 certified to produce sterile topical hemostats with chitosan for wound management.
Comparison of Two Methods for Transradial Hemostasis After Cardiac Catheterization and Impact on Post-Procedure Efficiency, January 2024.
A novel method using manual pressure on a hemostatic pad and ulnar compression as an alternative for radial sheath removal, published in March 2018.
A presentation on the clinical efficacy of SoftSeal-STF Hemostatic Pad at the American College of Cardiology's 66th Annual Scientific Session in 2017.
Chitogen's U.S. contract manufacturer is ISO 13485 certified to produce sterile topical hemostats with chitosan for wound management.